BioLASCO Taiwan Co. Ltd.(TW:6662)
NT$28.400.00 (0.00%)
TW:6662
BioLASCO Taiwan Co. Ltd. financials statements
NT$28.40
At close:0.00 (0.00%)
BioLASCO Taiwan Co. Ltd. (6662) Income Statement
BioLASCO Taiwan Co. Ltd. Income Statement
Last quarter (Q2 2026), BioLASCO Taiwan Co. Ltd.'s total revenue was NT$64.51M, a decrease of 8.21% from the same quarter last year. In Q2, BioLASCO Taiwan Co. Ltd.'s net income was NT$10.38M. See BioLASCO Taiwan Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 262.66M | NT$ 292.50M | NT$ 264.72M | NT$ 235.91M | NT$ 227.58M | |
| NT$ 101.62M | NT$ 114.76M | NT$ 104.35M | NT$ 104.49M | NT$ 105.11M | |
| NT$ 53.58M | NT$ 59.06M | NT$ 53.59M | NT$ 55.22M | NT$ 51.18M | |
| Depreciation and Amortization | NT$ 11.53M | NT$ 10.97M | NT$ 10.57M | NT$ 9.96M | NT$ 9.99M |
| NT$ 59.58M | NT$ 67.64M | NT$ 73.86M | NT$ 59.50M | NT$ 67.34M | |
| NT$ 48.04M | NT$ 55.71M | NT$ 50.76M | NT$ 54.22M | NT$ 57.35M | |
| NT$ 1.52M | NT$ -789.00K | NT$ 11.23M | NT$ 3.87M | NT$ -913.00K | |
| NT$ 49.56M | NT$ 54.92M | NT$ 61.99M | NT$ 53.14M | NT$ 56.44M | |
| NT$ 42.43M | NT$ 44.03M | NT$ 49.74M | NT$ 42.31M | NT$ 45.15M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.66 | NT$ 1.72 | NT$ 1.94 | NT$ 1.65 | NT$ 1.76 |
| Diluted EPS | NT$ 1.65 | NT$ 1.72 | NT$ 1.94 | NT$ 1.65 | NT$ 1.76 |
| Weighted Average Shares Outstanding | 25.61M | 25.61M | 25.64M | 25.61M | 25.61M |
| Weighted Average Shares Outstanding (Diluted) | 25.65M | 25.65M | 25.66M | 25.61M | 25.66M |
Currency in TWD
